#Germany #FLEX #Merck KGaA #Darmstadt #Drug Delivery

Flex and Merck KGaA Win the 2025 PDA Drug Delivery Innovation Award

In a remarkable collaboration between Flex, a prominent manufacturing leader, and Merck KGaA based in Darmstadt, Germany, the duo has clinched the prestigious 2025 PDA Drug Delivery Innovation Award. This recognition was bestowed during the 2025 PDA Universe of Pre-Filled Syringes and Injection Devices Conference held in Vienna, Austria. The award acknowledges their joint efforts aimed at enhancing patient outcomes through advanced digital health solutions.

The winning submission, titled "Empowering Patients: The Benefits of Connected Injection Devices on Health Outcomes – A Focus on Autoinjectors," highlights how an integrated digital ecosystem can significantly affect chronic disease management. This partnership has been a collaborative journey spanning nearly two decades, during which Flex and Merck KGaA have focused on creating patient-centric drug delivery systems that enhance therapy adherence and improve both patient experiences and healthcare providers' decision-making processes.

One key innovation from their collaboration is a connected autoinjector solution which merges a smart injection device with a robust cloud-based data system. This system offers a mobile application designed for patients and a monitoring dashboard for healthcare professionals, all aimed at improving the efficiency of treatments. Key features include automated injection, real-time data sharing, customizable settings, and user-friendly interfaces. As a result, both patients and healthcare providers stand to benefit through better treatment efficiency and outcomes.

Riccardo Butta, the president of Flex’s Health Solutions division, expressed pride in receiving this prestigious award alongside their long-term partner, stating, "This recognition reflects our shared commitment to patient-centric design, digital innovation, and advanced manufacturing excellence." He emphasized that their joint mission is to foster solutions that not only enhance patient adherence but also facilitate personalized care and ultimately contribute to better health outcomes.

The collaboration between Flex and Merck KGaA exemplifies how sustained partnerships, driven by technical excellence, can lead to impactful innovations in the healthcare landscape. For those interested in learning more about Flex's capabilities in drug delivery, detailed information can be found on their official website at Flex Healthcare.

Flex is well-regarded as the manufacturing partner of choice for leading brands, assisting them in designing, building, and managing products that endeavor to improve the world. With a global presence across 30 countries, the company specializes in advanced manufacturing and supply chain solutions, innovative products, and lifecycle services that support customers from initial concepts to scalable production. In an era where artificial intelligence plays an important role, Flex is also facilitating faster deployment of data centers by tackling challenges related to power, heat, and scalability through cutting-edge technologies.

For more information on Flex's innovative approach and solutions in the pharmaceutical sector, the company invites stakeholders to explore their website and reach out for potential collaborations, inquiries, or media engagements.